Due to a production error, there was a mistake in Table 4 as published. The heading “Index” was incorrectly repeated and the subheadings “VATS(n=78)”, “RATS (n=142)”, “P”, “VATS”, “RATS”, and “P” were positioned above the incorrect columns. The corrected Table 4 appears below.
Table 4
| Without IPTW | With IPTW | |||||
|---|---|---|---|---|---|---|
| Index | VATS(n=78) | RATS (n=142) | P | VATS | RATS | P |
| 90-day mortality | 0(0) | 0(0) | >0.990 | 0% | 0% | >0.990 |
| LOS after surgery, mean (SD), d | 6.01(3.00) | 6.78(4.07) | 0.145 | 6.18(3.11) | 6.75(4.22) | 0.298 |
| VAS score after surgery, mean (SD) | 4.41(0.93) | 3.77(1.21) | 0.002 | 4.47(0.97) | 3.71(1.22) | <0.001 |
| VAS score at discharge, mean (SD) | 1.71(0.68) | 1.27(0.57) | 0.267 | 1.69(0.67) | 1.31 (0.56) | 0.375 |
| ADL score at discharge, mean (SD) | 59.49(11.29) | 62.22(12.27) | 0.106 | 59.60(11.25) | 62.27(12.22) | 0.138 |
| Drainage volume, mean (SD), ML | 452.05(399.10) | 439.33(304.18) | 0.791 | 459.00(300.06) | 431.37(288.50) | 0.461 |
| Drug cost, mean (SD), $ | 1320.70(638.73) | 1579.58(1178.16) | 0.355 | 1336.06(668.59) | 1571.83(1359.65) | 0.087 |
Unadjusted and IPTW adjusted perioperative outcomes.
SD, standard deviation; LOS, length of stay; VAS, visual analogue scale; ADL, activities of daily living, IPTW, inverse probability treatment weight; VATS, video-assisted thoracic surgery; RATS, robotic-assisted thoracic surgery.
The publisher apologizes for this mistake. The original version of this article has been updated.
Summary
Keywords
non-small-cell lung cancer, neoadjuvant chemoimmunotherapy, robotic-assisted thoracic surgery, video-assisted thoracic surgery, safety and feasibility
Citation
Frontiers Production Office (2023) Erratum: Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer. Front. Oncol. 13:1208634. doi: 10.3389/fonc.2023.1208634
Received
19 April 2023
Accepted
19 April 2023
Published
03 May 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2023
Updates
Copyright
© 2023 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.